The hepatitis C virus (HCV) has developed a small membrane protein, p7, which remarkably can self-assemble into a large channel complex that selectively conducts cations [1] [2] [3] [4] . We wanted to examine the structural solution that the viroporin adopts in order to achieve selective cation conduction, because p7 has no homology with any of the known prokaryotic or eukaryotic channel proteins. The activity of p7 can be inhibited by amantadine and rimantadine 2,5 , which are potent blockers of the influenza M2 channel 6 and licensed drugs against influenza infections 7 . The adamantane derivatives have been used in HCV clinical trials 8 , but large variation in drug efficacy among the various HCV genotypes has been difficult to explain without detailed molecular structures. Here we determine the structures of this HCV viroporin as well as its drug-binding site using the latest nuclear magnetic resonance (NMR) technologies. The structure exhibits an unusual mode of hexameric assembly, where the individual p7 monomers, i, not only interact with their immediate neighbours, but also reach farther to associate with the i12 and i13 monomers, forming a sophisticated, funnel-like architecture. The structure also points to a mechanism of cation selection: an asparagine/ histidine ring that constricts the narrow end of the funnel serves as a broad cation selectivity filter, whereas an arginine/lysine ring that defines the wide end of the funnel may selectively allow cation diffusion into the channel. Our functional investigation using wholecell channel recording shows that these residues are critical for channel activity. NMR measurements of the channel-drug complex revealed six equivalent hydrophobic pockets between the peripheral and pore-forming helices to which amantadine or rimantadine binds, and compound binding specifically to this position may allosterically inhibit cation conduction by preventing the channel from opening. Our data provide a molecular explanation for p7mediated cation conductance and its inhibition by adamantane derivatives.
The hepatitis C virus (HCV) has developed a small membrane protein, p7, which remarkably can self-assemble into a large channel complex that selectively conducts cations [1] [2] [3] [4] . We wanted to examine the structural solution that the viroporin adopts in order to achieve selective cation conduction, because p7 has no homology with any of the known prokaryotic or eukaryotic channel proteins. The activity of p7 can be inhibited by amantadine and rimantadine 2, 5 , which are potent blockers of the influenza M2 channel 6 and licensed drugs against influenza infections 7 . The adamantane derivatives have been used in HCV clinical trials 8 , but large variation in drug efficacy among the various HCV genotypes has been difficult to explain without detailed molecular structures. Here we determine the structures of this HCV viroporin as well as its drug-binding site using the latest nuclear magnetic resonance (NMR) technologies. The structure exhibits an unusual mode of hexameric assembly, where the individual p7 monomers, i, not only interact with their immediate neighbours, but also reach farther to associate with the i12 and i13 monomers, forming a sophisticated, funnel-like architecture. The structure also points to a mechanism of cation selection: an asparagine/ histidine ring that constricts the narrow end of the funnel serves as a broad cation selectivity filter, whereas an arginine/lysine ring that defines the wide end of the funnel may selectively allow cation diffusion into the channel. Our functional investigation using wholecell channel recording shows that these residues are critical for channel activity. NMR measurements of the channel-drug complex revealed six equivalent hydrophobic pockets between the peripheral and pore-forming helices to which amantadine or rimantadine binds, and compound binding specifically to this position may allosterically inhibit cation conduction by preventing the channel from opening. Our data provide a molecular explanation for p7mediated cation conductance and its inhibition by adamantane derivatives.
Many viruses have developed integral membrane proteins to transport ions and other molecules across the membrane barrier to aid various steps of viral entry and maturation 9, 10 . These membrane structures, known as viroporins, usually adopt minimalist architectures that are significantly different from those of bacterial or eukaryotic ion channels. Therefore, understanding the structural basis of how viroporins function broadens our knowledge of channels and transporters while generating new opportunities for therapeutic intervention.
The viroporin formed by the HCV p7 protein has been sought after as a potential anti-HCV drug target 5, 11 . p7 is a 63-residue membrane protein that oligomerizes to form ion channels with cation selectivity, for Ca 21 over K 1 and Na 1 (refs 2, 3, 12, 13) , and a more recent study has also reported p7-mediated H 1 intracellular conductance 14 . The p7 channel is required for viral replication 15 ; it has been shown to facilitate efficient assembly and release of infectious virions 16, 17 , although the precise mechanism of these functions remains unclear. The channel activity can be inhibited by adamantane and long alkyl chain iminosugar derivatives and hexamethylene amiloride in vitro, with varying reported efficacies 2, 3, 12, 13 . In addition to ion conduction, p7 has been shown to specifically interact with the non-structural HCV protein NS2, indicating that its channel activity could be regulated 18, 19 .
There is not yet a detailed structure of the p7 channel, although a number of NMR studies showed that the p7 monomer has three helical segments: two in the amino-terminal half of the sequence and one near the carboxy terminus 12, 20 . A single-particle electron microscopy (EM) study obtained a 16 Å resolution electron density map of the p7 oligomer using the random conical tilting approach 4 . The map shows that the p7 channel is a 42-kDa hexamer and adopts a flower-like shape that does not resemble any of the known ion channel structures in the database.
It is not known how the small p7 polypeptide assembles into what appears to be a complex channel structure, and whether the viroporin has adopted novel structural elements for cation selectivity and channel gating. Amantadine or rimantadine blocks the influenza M2 channel by binding to the small pore formed by four transmembrane helices [21] [22] [23] , but the pore of the p7 hexamer is expected to be much bigger and it is thus unclear how these small molecules would fit. We sought to address these questions by determining detailed structures of the p7 hexamer and its drug-binding site.
We systematically tested p7 amino acid sequences from various HCV genotypes and found that the sequence from genotype 5a (EUH1480 strain) generated samples that were sufficiently soluble for structure determination ( Supplementary Fig. 1 ). This p7 construct, designated here as p7(5a), could be efficiently reconstituted in dodecylphosphocholine (DPC) micelles at near physiological pH and generated high-quality NMR spectra ( Supplementary Fig. 2 ). Negativestain EM of the DPC-reconstituted p7(5a) in NMR buffer showed hexameric, flower-shaped particles that are similar to those in the electron micrographs of the p7 (JFH-1 strain, genotype 2a) hexamer in dihexanoyl-phosphatidyl-choline (DHPC) micelles used earlier for single-particle reconstruction 4 ( Supplementary Fig. 3 ). Moreover, isothermal titration calorimetry and NMR chemical shift perturbation analyses of p7(5a)-rimantadine interaction showed that the drug binds specifically to the reconstituted protein with a binding constant (K d ) from 50 to 100 mM at 3 mM detergent concentration ( Supplementary  Figs 4 and 5 ). The above results together indicate that the p7(5a) polypeptides reconstituted in DPC micelles form structurally relevant hexamers.
Structure determination of the p7(5a) hexamer by NMR used an approach taken earlier for oligomeric membrane proteins [24] [25] [26] , which involves: (1) determination of local structures of the monomers; and (2) assembly of the oligomer with intermonomer distance restraints and orientation constraints. The NMR-derived restraints define an ensemble of structures with backbone root mean squared deviation (r.m.s.d.) of 0.74 Å (Fig. 1a ). Each monomer consists of an N-terminal helix (H1) from residues 5-16, a middle helical segment (H2), with a kink at Gly 34, from residues 20-41, and a C-terminal helix (H3) from residues 48-58. These secondary structures are consistent with earlier NMR studies of p7 monomers in DHPC detergent and organic solvent 12, 20 . There are no intramonomer contacts (Fig. 1a ). The monomers are intertwined to form a tightly packed channel, where H1 and H2 form the channel interior and H3 is lipid-facing and packs against H2 of the i12 and H1 of the i13 monomer ( Fig. 1a, b ). The intermonomer association between H3 and H2 appears to be stabilized by interaction involving conserved residues such as Trp 30, Tyr 42 and Leu 52, and the contacts between H3 and H1 are mostly between the alanine-rich region of H1 (residues 10-15) and Ala 61 and Ala 63 of H3 (Fig. 1c ). The overall structure of the p7(5a) hexamer has a flowerlike shape that agrees with the EM map (EM database ID 1661), fitting to the map with a correlation coefficient of 0.94 (Fig. 1d ).
The channel cavity has a funnel profile that resembles a champagne flute and is largely hydrophilic (Fig. 2a ). The H2 helices form the wide cylindrical region (internal diameter (ID) ,12 Å ) by packing with each other at large angles (angle between adjacent helices approximately 247u), and the H1 helices assemble at smaller packing angles (approximately 234u) to form the narrow conical region of the funnel (smallest ID at 6.8 Å ). Residues 17-19 constitute the flexible joint between H1 and H2; their NMR resonances are significantly broader than other regions of the protein, indicating the presence of conformational exchange.
The channel architecture described above represents a novel topology and exemplifies how HCV has optimized the short p7 polypeptide to achieve a rather complex channel structure. We next addressed what elements are involved in cation conduction and gating. An in-depth examination of the channel interior found two strongly conserved polar residues with salient structural features ( Fig. 2b) . One is Asn 9, which forms a ring of carboxamide that constricts the conical region of the channel (Fig. 2c ). Residue 9 is asparagine in all strains except in genotype 2 viruses, where it is substituted with histidine. Both asparagines and histidines have affinity for monovalent and divalent cations. We propose that the Asn 9 ring serves as a broad selectivity filter that dehydrates cations, allowing them to pass the hydrophobic ring formed by Ile 6. The Ile 6 ring defines the narrowest point of the channel and probably serves as a hydrophobic gate. Another feature is the Arg 35 ring that defines the wider, C-terminal end of the channel (Fig. 2b ). Placement of a positively charged ring on the other end of the pore was incomprehensible to us initially because it can repel cations. But the recent structure of an Orai Ca 21 channel also revealed a stretch of basic residues in the ion-conducting pore 27 . We propose that one role of Arg 35 is to bind and obstruct anions at the pore entrance while allowing cations to diffuse into the pore. In this model, cation conduction is unidirectional from the C-to N-terminal end of the channel.
To test the above hypotheses, we established an assay that uses the two-electrode voltage-clamp technique to record p7-mediated current in Xenopus oocytes (see Methods). Owing to the poor stability of oocytes that overexpress p7(5a), p7 (JFH-1 strain, genotype 2a) was used instead for these experiments. As expected because of the proposed role of residue 9 in selectively dehydrating cations, replacing His 9 of p7(2a) with alanine caused a ,70% reduction in channel conductance at 180 mV (Fig. 2d ). The proposed role of Arg 35 indicates that placing negatively charged residues at the channel entrance would bind cations and hinder their diffusion into the pore, and indeed the Arg35Asp mutation also reduced conductance by ,70% (Fig. 2d ).
We next investigated the mechanism of amantadine binding to the p7 channel using proteins that are 15 N-labelled and deuterated so that nuclear Overhauser enhancement (NOE) between the protein backbone Figure 1 | NMR structure of the p7(5a) hexamer and its comparison to the EM map. a, Ensemble of 15 low-energy structures calculated using NMR restraints summarized in Supplementary Table 1 . b, Two-dimensional drawing illustrating the intermonomer interactions among the H1 (blue), H2 (yellow) and H3 (pink) helical segments that are responsible for the hexameric assembly. c, Three-dimensional cartoon representation describing the global arrangement of helical segments and amino acids that seem to have a role in the packing of H3 against H1 and H2. d, Fitting the lowest-energy structure from the ensemble to the 16 Å EM map (EM database ID 1661) 4 . The fitting correlation is 0.94 as calculated with the program Chimera.
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amide protons and drug protons could be measured unambiguously. At 10 mM amantadine (not corrected for drug partitioning to detergent micelles), the 15 N-edited nuclear Overhauser enhancement spectroscopy (NOESY) spectrum showed NOE crosspeaks between the adamantane protons and the amide protons of Val 26, Leu 55, Leu 56 and Arg 57 ( Fig. 3a ). We then identified contacts between the drug and protein side chains using protein that is ( 1 H/ 13 C)-labelled at the methyl positions of alanines, valines and leucines but is otherwise deuterated. In this case, the 13 C-edited NOESY showed several methyl-drug NOEs (Fig. 3b) . These NOEs were used to dock amantadine into the structure determined in the absence of drug. In doing so, we emphasize that the relevance of the p7-amantadine complex is confined to only the drug-binding region because we do not know how and to what degree does drug binding alter the global conformation of the channel. The relatively poor stability of the protein-drug complex at the current stage of our study precludes full-scale structure determination. Nonetheless the available NMR data show that the drug adamantane binds to six equivalent hydrophobic pockets between the pore-forming and peripheral helices (Fig. 3c) . The pocket consists of Leu 52, Val 53 and Leu 56 from H3, and Phe 20, Val 25 and Val 26 from H2. The amantadine amino group on average points to the channel lumen. The same NOESY spectrum as above recorded using a sample with 5 mM rimantadine indicates that rimantadine binds to the same pocket with the methyl and amino groups pointing to the lumen (Supplementary Fig. 6 ).
The binding site is overall consistent with a mutational study showing that mutations in residues 50-55 significantly reduce drug sensitivity of the channel 28 . It is also consistent with a Leu20Phe mutation in genotype 1b virus originally identified in clinical trials that confers amantadine resistance 8, 29 . In the p7(5a) structure, residue 20 is an integral part of the drug pocket and is in direct contact with the drug adamantane. Therefore, replacing Leu 20 in p7(1b) with phenylalanine is expected to reduce hydrophobic interaction with the drug. Elucidation of previous functional data in the context of the structure suggests that the binding site shown in Fig. 3c is relevant to drug inhibition and that interactions between the drug adamantane and protein hydrophobic residues are critical for inhibition. Variations in the hydrophobicity of the binding pocket among the p7 variants ( Supplementary  Fig. 7 ) thus explain the large differences in drug efficacies observed between different HCV genotypes.
We have learnt from KcsA and other channels that a gated ion channel generally adopts two essential features: pore elements that provide ion selectivity, and a gating mechanism that can transiently 
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open the channel to allow ion permeation. By virtue of being a funnel, the p7 structure indicates that the tip of the funnel represented by the Ile 6 and Asn 9 rings is the key region for channel gating (Fig. 4) . The role of the Asn 9 ring is to provide ion selectivity by recruiting and dehydrating cations near the funnel exit, whereas the Ile 6 ring is a hydrophobic constriction that would prevent water from freely passing through. Channel activation may involve reorientation of the H1 helices that widens the funnel tip, analogous to the dynamic C-terminal helix of KcsA 30 , and such structural rearrangement can be afforded by the flexible hinge between H1 and H2, the intervening loop between H2 and H3, and the C-terminal tail that 'latches' onto H1. We thus propose that binding of adamantane derivatives inhibit channel activity by restricting the structural rearrangement. Our NMR titration data ( Supplementary Fig. 5c ) are consistent with this proposal, which shows that in the absence of rimantadine, the Ile 6 methyl resonance is split into an intense and weak peak, possibly corresponding to the open and closed state, respectively, and that increasing the drug concentration shifts the equilibrium that make the weak peak stronger. Although rigorous testing of the model is needed, the preliminary observation suggests the existence of multiple states of the p7 channel.
METHODS SUMMARY
The p7 sequence from HCV genotype 5a was mutated at five unconserved positions to improve protein stability and to facilitate NMR analyses (see details in Supplementary Fig. 1 ). The protein was expressed as a fusion to His 9-trpLE that formed inclusion bodies, and purified and reconstituted in DPC as previously described 23, 25 . A typical NMR sample contains 0.8 mM protein (monomer concentration), 200 mM DPC and 25 mM MES (pH 6.5). For structure determination, the secondary structures of the p7(5a) monomers in the hexamer were first determined using standard NOE experiments. We then used a mixed sample in which 50% of the monomers are ( 15 N/ 2 H)-labelled and 50% 13 C-labelled to measure exclusively NOEs between the 15 N-attached protons of one subunit and the 13 C-attached protons of the neighbouring subunits. This experiment provided key intermonomer NOEs between adjacent H1 and H2 helices for assembling the central cavity of the hexamer ( Supplementary Fig. 8a) . H3 was positioned based on orientation restraints from residual dipolar couplings (RDCs) and its intermonomer NOEs to H1 and H2 ( Supplementary Fig. 8b, c) . Structure calculation statistics are given in Supplementary Table 1 . Protein-drug contacts were identified using ( 15 N/ 2 H)-labelled protein so that NOEs between protein backbone amide protons and drug protons could be identified unambiguously. Additionally, NOEs between the drug and protein side-chain methyl groups were measured with a diagonal-suppressed carbon NOESY using ALV labelled protein (see Methods).
Functional p7 mutants were analysed using the standard protocol for twoelectrode voltage-clamp of Xenopus oocytes. After expressing the p7(2a) variants in oocytes, we recorded p7 currents across the oocyte plasma membrane at room temperature (,22 uC). For quantitative comparison of currents between the p7 variants, the protein expression levels in oocytes were examined using confocal microscopy. 
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METHODS
Sample preparation. The amino acid sequence of p7 from genotype 5a was slightly modified to allow for efficient reconstitution and protein sample stability. In this sequence, Thr 1 is replaced with Gly, Ala 12 is replaced with Ser, and the three cysteines at positions 2, 27 and 44 are replaced with Ala, Thr and Ser, respectively ( Supplementary Fig. 1 ). The p7(5a) construct was cloned, expressed and purified as previously described 23, 25 . Briefly, the protein was expressed as a fusion to His9-trpLE that formed inclusion bodies. The peptide was released from the fusion protein by CNBr digestion and subsequently separated on a Proto-18C column by reverse-phase chromatography (more details given in Supplementary  Methods) . The lyophilized peptide was then dissolved in 6 M guanidine and DPC and refolded by dialysis against the NMR buffer. A typical NMR sample contains 0.8 mM protein (monomer concentration), 200 mM DPC and 25 mM MES (pH 6.5).
Assignment of NMR resonances. All NMR experiments were conducted at 30 uC on Bruker spectrometers equipped with cryogenic probes. Sequence-specific assignment of backbone chemical shifts was accomplished using three pairs of triple resonance experiments, recorded using a 15 N/ 13 C/ 2 H-labelled sample. The triple resonance experiments were relaxation optimized (TROSY) 31 , including HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, HN(CA)CO and HNCO 32 . Protein side-chain aliphatic and aromatic resonances were assigned using a combination of NOESYs including 15 N-edited NOESY-TROSY (60 ms NOE mixing time, t NOE ) and 13 C-edited NOESY-HSQCs (t NOE 5 100 ms). Specific stereo assignment of the methyl groups of valines and leucines were obtained from a constant-time 1 H-13 C HSQC spectrum recorded using a 15% 13 C-labelled sample 33 . Assignment of local NOEs for determining the secondary structures. The same 15 N-edited NOESY-TROSY and 13 C-edited NOESY-HSQC above with short t NOE were used to assign local NOEs. Combining the NOE restraints with chemical shifts, we could very precisely define the helical and loop regions of the individual monomers. Measurement of residual dipolar coupling (RDC) constants. The backbone 1 H-15 N RDCs were measured using a modified approach 34 of the strain-induced alignment in a gel method 35, 36 . In this experiment the p7(5a) channel in DPC micelles was soaked into a cylindrically shaped polyacrylamide gel (4.5%), initially of 6 mm diameter, which was subsequently radially compressed to fit within the 4.2-mm inner diameter of an open-ended NMR tube. The 1 H-15 N RDCs were obtained from 1 J NH /2 and ( 1 J NH 1 1 D NH )/2, which were measured by interleaving a regular gradient-enhanced HSQC and a gradient-selected TROSY 37 . The largest 1 H-15 N RDC measured is 33.5 Hz. Assignment of intermonomer NOEs. Intermonomer NOEs between protein backbone amide and side-chain methyl protons was assigned using a sample that was reconstituted with a 1:1 mixture of 15 N-, 2 H-labelled p7(5a) peptide and 13 C-labelled peptide. Recording a 15 N-edited NOESY-TROSY (t NOE 5 300 ms) on a 900 MHz spectrometer with this sample allowed exclusive detection of NOE crosspeaks between the 15 N-attached protons of one monomer and the 13 Cattached protons of other monomers. The intermonomer NOEs between the neighbouring H1 helices and neighbouring H2 helices effectively defined the central cavity formed by these helices. The initial structural solution of the pore assembly then allowed us to assign complementary and self-consistent intermonomer NOEs between the aliphatic and aromatic protons in a pair of 15 N-edited NOESY-TROSY and 13 C-edited NOESY-HSQC recorded using a 15 N-, 13 C-labelled sample. These spectra were recorded with t NOE of 120 ms and 150 ms, respectively.
The packing of H1 and H2 helices between the adjacent monomers and RDCderived orientation constraints together positioned the H3 helix of monomer i to be in contact with H2 of the i12 and H1 of the i13 monomers, and this conformation was confirmed by the unambiguous amide-methyl NOEs between H3 and H1/H2. The conformation as defined by the intermonomer NOEs was subjected to numerous rounds of self-consistency test with the NOE crosspeaks in the 13 C-edited NOESY-HSQC spectrum to ensure that all NOEs are consistent with the structure. The overall distribution of intermonomer NOEs is illustrated in Supplementary Fig. 7 . Assignment of NOEs between protein and drug. We prepared a sample containing 15 N-, 2 H-labelled p7(5a), 10 mM amantadine (or 5 mM rimantadine), and perdeuterated DPC. The sample was used to record a 15 N-edited NOESY-TROSY (t NOE 5 300 ms) on a 900 MHz spectrometer. This experiment allowed exclusive detection of NOEs between the exchangeable amide protons and the drug protons. For assigning NOEs between the protein side-chain methyl protons and the drug protons, we prepared the ALV-labelled protein that is 1 H-, 13 C-labelled at the methyl positions of alanines, valines and leucines but is otherwise deuterated.
The NOEs were measured using a 13 C-edited NOESY with diagonal suppression, that is, interleaving two experiments: one with NOE mixing (300 ms) of the H z magnetization (NOE crosspeaks) and the other with mixing of the H z C z magnetization (no NOE crosspeaks) 38 . Subtracting the two spectra mostly cancelled the strong methyl diagonal peaks (,0.8 p.p.m.) and thereby unveiled the weak methyl-drug NOEs at ,1.7 p.p.m. Structure calculation of the p7(5a) hexamer. Structures were calculated using the program XPLOR-NIH 39 . The monomer structures (mainly the secondary structures) were first calculated using intramonomer NOE-derived distance restraints, backbone dihedral restraints derived from chemical shifts using the TALOS program 40 , and RDC restraints. A total of 10 monomer structures were calculated using a standard simulated annealing (SA) protocol. Six copies of the lowest-energy monomer structure were used to construct an initial model of the hexamer using intermonomer NOE restraints collected from the mixed-labelled sample for the H1 and H2 helical segments. For each intermonomer restraint between two adjacent monomers, six identical distance restraints were assigned respectively to all pairs of neighbouring monomers to satisfy the condition of C6 rotational symmetry (as indicated by the EM data). The assembled hexamer was then subjected to refinement against RDCs to accurately orient the three helical segments. Finally, using the SA protocol, the hexamer was refined against the complete set of NOE restraints (including intramonomer and intermonomer distance restraints), dihedral restraints and RDC restraints. A total of 60 hexamer structures were calculated and 15 low-energy structures were selected as the structural ensemble. Ramachandran plot statistics for the structure ensemble, calculated using PROCHECK 41 , are as follows: most favoured (96.6%), additionally allowed (2.8%), generously allowed (0.6%) and disallowed (0.0%). Whole-cell channel recording assay for p7. The cRNA of p7(2a) variants was synthesized and injected into Xenopus laevis oocytes at ,15 ng per oocyte. After about 16-30 h of expression, healthy oocytes were collected and subjected to channel recording using the two-electrode voltage-clamp technique 42 . The oocytes were first bathed in standard ORi solution (90 mM NaCl, 2 mM KCl, 2 mM CaCl 2 and 5 mM MOPS, pH 7.4) before being impaled with two microelectrodes. For recording p7-mediated current, we used a voltage-clamp protocol consisting of rectangular voltage steps from 2100 to 180 mV in 10-mV increments, applied from a holding voltage of 260 mV. Expression levels of the p7 variants in oocytes were examined by confocal microscopy using haemagglutinin-tagged p7. More experimental details are described in Supplementary Methods.
